Crawford Investment Counsel’s Cantel Medical Corporation CMD Stock Holding History

Crawford Investment Counsel’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-67,693	Closed	-$5.41M	–	297
2021 Q1	$5.41M	Sell	67,693 -5,150	-7%	-$402K	0.12%	113
2020 Q4	$5.74M	Sell	72,843 -4,000	-5%	-$235K	0.14%	95
2020 Q3	$3.38M	Hold	76,843	–	–	0.09%	120
2020 Q2	$3.4M	Buy	+76,843	New	+$2.87M	0.1%	118

Crawford Investment Counsel's CMD Position: Q2 2021 in Review

Crawford Investment Counsel sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 67,693 shares — an estimated $5.41M sold.

Crawford Investment Counsel first reported a position in CMD in Q2 2020 and held it in 4 quarters. The position peaked at $5.74M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Crawford Investment Counsel reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Crawford Investment Counsel sold 67,693 Cantel Medical Corporation shares in Q2 2021, an estimated $5.41M.
Crawford Investment Counsel first reported a position in Cantel Medical Corporation in Q2 2020 and held it in 4 quarters.
Crawford Investment Counsel's Cantel Medical Corporation position peaked at $5.74M in Q4 2020.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Crawford Investment Counsel's 13F filing for Q2 2021, filed 16 Aug 2021.